340 samples
Export
<<< of 17>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterGPL15520 Remove filterXLSX
GSM6170899
3hExo Mut 1 10hrs into S Phase
SRA 1
  • Link icon GPL15520
William Marzluff Aug 01, 2022
GSM6170900
3hExo Mut 2 10hrs into S Phase
SRA 1
  • Link icon GPL15520
William Marzluff Aug 01, 2022
GSM5008915
CAST-seq centromeric CCR5#1 CRISPR/Cas9 treated CD34+ cells, Day1 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008889
CAST-seq centromeric CCR5#1 CRISPR/Cas9 treated CD34+ cells, Day1 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008916
CAST-seq centromeric CCR5#1 CRISPR/Cas9 treated CD34+ cells, Day14 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008890
CAST-seq centromeric CCR5#1 CRISPR/Cas9 treated CD34+ cells, Day14 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008917
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day1 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008891
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day1 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008920
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day14 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008894
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day14 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008918
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day4 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008892
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, Day4 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008919
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, duplicate Day4 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008893
CAST-seq centromeric CCR5#2 CRISPR/Cas9 treated CD34+ cells, duplicate Day4 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008895
CAST-seq centromeric CCR5#2 CRISPR/HiFiCas9 treated CD34+ cells, Day1 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008898
CAST-seq centromeric CCR5#2 CRISPR/HiFiCas9 treated CD34+ cells, Day14 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008896
CAST-seq centromeric CCR5#2 CRISPR/HiFiCas9 treated CD34+ cells, Day4 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008897
CAST-seq centromeric CCR5#2 CRISPR/HiFiCas9 treated CD34+ cells, duplicate Day4 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008925
CAST-seq centromeric CCR5#2 TALEN treated CD34+ cells, Day1 non-treated control
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021
GSM5008903
CAST-seq centromeric CCR5#2 TALEN treated CD34+ cells, Day1 post treatment
SRA 1
  • Link icon GPL15520
Geoffroy Andrieux Feb 14, 2021